$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * AstraZe
Imagine Holding ChemoCentryx (NASDAQ:CCXI) Shares While The Price Zoomed 656% Higher
10:59am, Friday, 01'st May 2020
For us, stock picking is in large part the hunt for the truly magnificent stocks. Mistakes are inevitable, but a...
Edited Transcript of TECH earnings conference call or presentation 30-Apr-20 1:00pm GMT
01:23am, Friday, 01'st May 2020
Q3 2020 Bio-Techne Corp Earnings Call
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs May 1.)
Arcturus Therapeutics Ltd (...
Traders Purchase High Volume of Call Options on ChemoCentryx (NASDAQ:CCXI)
10:24am, Thursday, 30'th Apr 2020
ChemoCentryx Inc (NASDAQ:CCXI) was the target of unusually large options trading activity on Wednesday. Investors acquired 3,724 call options on the company. This is an increase of approximately 571%
Emerald Mutual Fund Advisers Trust Buys BellRing Brands Inc, Blueprint Medicines Corp, Science ...
12:00am, Thursday, 30'th Apr 2020Analysts Estimate ChemoCentryx (CCXI) to Report a Decline in Earnings: What to Look Out for
04:31pm, Monday, 27'th Apr 2020
ChemoCentryx (CCXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate ChemoCentryx (CCXI) to Report a Decline in Earnings: What to Look Out for
04:31pm, Monday, 27'th Apr 2020
ChemoCentryx (CCXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate ChemoCentryx (CCXI) to Report a Decline in Earnings: What to Look Out for
12:00am, Monday, 27'th Apr 2020ChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Quarterly Sales of $8.90 Million
07:28am, Sunday, 26'th Apr 2020
Equities research analysts expect ChemoCentryx Inc (NASDAQ:CCXI) to post sales of $8.90 million for the current quarter, Zacks reports. Five analysts have made estimates for ChemoCentryx’s earnings,
Zacks Investment Research Upgrades ChemoCentryx (NASDAQ:CCXI) to "Buy"
07:48am, Saturday, 25'th Apr 2020
Zacks Investment Research upgraded shares of ChemoCentryx (NASDAQ:CCXI) from a hold rating to a buy rating in a report issued on Tuesday, Zacks.com reports. Zacks Investment Research currently has $58
Biotech Melt-Up
01:00pm, Thursday, 23'rd Apr 2020
A high daily death toll suggests a much more careful and measured reopening of the economy will be possible, not a quick-paced one. The pandemic thrusts the bio
Here's Why Momentum Investors Will Love ChemoCentryx (CCXI)
04:00pm, Wednesday, 22'nd Apr 2020
Does ChemoCentryx (CCXI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why Momentum Investors Will Love ChemoCentryx (CCXI)
04:00pm, Wednesday, 22'nd Apr 2020
Does ChemoCentryx (CCXI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Sign In
Buy CCXI